BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

128 related articles for article (PubMed ID: 38038494)

  • 1. A Single-Cell CRISPR Screen Reveals Intratumoral CD8+ T-cell Fate Regulomes.
    Cancer Discov; 2024 Jan; 14(1):17. PubMed ID: 38038494
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Single-cell CRISPR screens in vivo map T cell fate regulomes in cancer.
    Zhou P; Shi H; Huang H; Sun X; Yuan S; Chapman NM; Connelly JP; Lim SA; Saravia J; Kc A; Pruett-Miller SM; Chi H
    Nature; 2023 Dec; 624(7990):154-163. PubMed ID: 37968405
    [TBL] [Abstract][Full Text] [Related]  

  • 3. In vivo T cell CRISPR screens reveal immunotherapeutic targets.
    Bradley CA
    Nat Rev Cancer; 2019 Nov; 19(11):606. PubMed ID: 31492928
    [No Abstract]   [Full Text] [Related]  

  • 4. In vitro modeling of CD8
    Wu JE; Manne S; Ngiow SF; Baxter AE; Huang H; Freilich E; Clark ML; Lee JH; Chen Z; Khan O; Staupe RP; Huang YJ; Shi J; Giles JR; Wherry EJ
    Sci Immunol; 2023 Aug; 8(86):eade3369. PubMed ID: 37595022
    [TBL] [Abstract][Full Text] [Related]  

  • 5. CRISPR screening reveals mechanisms of IgE+ B-cell constraint.
    Awan SF; Haque TT; Kubala SA
    Allergy; 2022 Oct; 77(10):3163-3164. PubMed ID: 35708917
    [No Abstract]   [Full Text] [Related]  

  • 6. [Advances in application of clustered regularly interspaced short palindromic repeats (CRISPR)/CRISPR-associated 9 system in stem cells research].
    Sun SJ; Huo JH; Geng ZJ; Sun XY; Fu XB
    Zhonghua Shao Shang Za Zhi; 2018 Apr; 34(4):253-256. PubMed ID: 29690746
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Systematic Immunotherapy Target Discovery Using Genome-Scale In Vivo CRISPR Screens in CD8 T Cells.
    Dong MB; Wang G; Chow RD; Ye L; Zhu L; Dai X; Park JJ; Kim HR; Errami Y; Guzman CD; Zhou X; Chen KY; Renauer PA; Du Y; Shen J; Lam SZ; Zhou JJ; Lannin DR; Herbst RS; Chen S
    Cell; 2019 Aug; 178(5):1189-1204.e23. PubMed ID: 31442407
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A CRISPR RNA-binding protein screen reveals regulators of RUNX1 isoform generation.
    Davis AG; Einstein JM; Zheng D; Jayne ND; Fu XD; Tian B; Yeo GW; Zhang DE
    Blood Adv; 2021 Mar; 5(5):1310-1323. PubMed ID: 33656539
    [TBL] [Abstract][Full Text] [Related]  

  • 9. How to make a better T cell: in vivo CRISPR screens have some answers.
    Villa M; Stanczak MA; Pearce EL
    Cell; 2021 Mar; 184(5):1135-1136. PubMed ID: 33667366
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Targeting differentiation blockade in AML: New hope from cell-surface-based CRISPR screens.
    Su R; Qing Y; Chen J
    Cell Stem Cell; 2021 Apr; 28(4):585-587. PubMed ID: 33798415
    [TBL] [Abstract][Full Text] [Related]  

  • 11. CRISPR Screens: The Right Tool for the Job.
    Russell A
    CRISPR J; 2019 Feb; 2():9-11. PubMed ID: 31021228
    [No Abstract]   [Full Text] [Related]  

  • 12. Generation of novel Il2rg-knockout mice with clustered regularly interspaced short palindromic repeats (CRISPR) and Cas9.
    Byambaa S; Uosaki H; Hara H; Nagao Y; Abe T; Shibata H; Nureki O; Ohmori T; Hanazono Y
    Exp Anim; 2020 Apr; 69(2):189-198. PubMed ID: 31801915
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Transcriptional and epigenetic regulators of human CD8
    McCutcheon SR; Swartz AM; Brown MC; Barrera A; McRoberts Amador C; Siklenka K; Humayun L; Ter Weele MA; Isaacs JM; Reddy TE; Allen AS; Nair SK; Antonia SJ; Gersbach CA
    Nat Genet; 2023 Dec; 55(12):2211-2223. PubMed ID: 37945901
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Application of clustered regularly interspaced short palindromic repeats- associated protein 9 gene editing technology for treatment of HBV infection].
    Wang YD; Liang QF; Li ZY; Zhao CY
    Zhonghua Gan Zang Bing Za Zhi; 2018 Nov; 26(11):860-864. PubMed ID: 30616324
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A CRISPR Take on Clonal Hematopoiesis.
    Swirski FK
    Circ Res; 2018 Jul; 123(3):313-314. PubMed ID: 30026373
    [No Abstract]   [Full Text] [Related]  

  • 16. Efficient CRISPR/Cas9 Gene Editing in Uncultured Naive Mouse T Cells for In Vivo Studies.
    Nüssing S; House IG; Kearney CJ; Chen AXY; Vervoort SJ; Beavis PA; Oliaro J; Johnstone RW; Trapani JA; Parish IA
    J Immunol; 2020 Apr; 204(8):2308-2315. PubMed ID: 32152070
    [TBL] [Abstract][Full Text] [Related]  

  • 17. An in-library ligation strategy and its application in CRISPR/Cas9 screening of high-order gRNA combinations.
    Lu Z; Ni K; Wang Y; Zhou Y; Li Y; Yan J; Song Q; Liu M; Xu Y; Yu Z; Guo T; Ma L
    Nucleic Acids Res; 2022 Jun; 50(11):6575-6586. PubMed ID: 35670669
    [TBL] [Abstract][Full Text] [Related]  

  • 18. CRISPR-on for Endogenous Activation of SMARCA4 Expression in Bovine Embryos.
    Alberio V; Savy V; Salamone DF
    Methods Mol Biol; 2022; 2495():129-148. PubMed ID: 35696032
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Correction of Hirschsprung-Associated Mutations in Human Induced Pluripotent Stem Cells Via Clustered Regularly Interspaced Short Palindromic Repeats/Cas9, Restores Neural Crest Cell Function.
    Lai FP; Lau ST; Wong JK; Gui H; Wang RX; Zhou T; Lai WH; Tse HF; Tam PK; Garcia-Barcelo MM; Ngan ES
    Gastroenterology; 2017 Jul; 153(1):139-153.e8. PubMed ID: 28342760
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Complementary CRISPR screen highlights the contrasting role of membrane-bound and soluble ICAM-1 in regulating antigen-specific tumor cell killing by cytotoxic T cells.
    Herzfeldt AK; Gamez MP; Martin E; Boryn LM; Baskaran P; Huber HJ; Schuler M; Park JE; Swee LK
    Elife; 2023 Sep; 12():. PubMed ID: 37732732
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.